A 2011 Cochrane review found that compared with other antidepressants, it is more likely to cause weight gain and sleepiness, but it is less likely to cause tremor than tricyclic antidepressants, and less likely to cause nausea and sexual dysfunction than SSRIs.<ref name=Cochrane2011/>

 


 
Very common (≥10% incidence) adverse effects include constipation, dry mouth, sleepiness, increased appetite, and weight gain.<ref name = DM/><ref name = AXIT>{{cite web|title=Axit Mirtazapine PRODUCT INFORMATION|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05345-3|work=TGA eBusiness Services|publisher=alphapharm|accessdate=15 October 2013|date=25 October 2011}}</ref><ref name = EMC>{{cite web|title=Mirtazapine 30 mg Tablets – Summary of Product Characteristics|date=20 March 2013|accessdate=24 October 2013|format=PDF|url=http://www.medicines.org.uk/emc/medicine/25201/SPC/Mirtazapine+30+mg+Tablets/|work=electronic Medicines Compendium|publisher=Sandoz Limited}}</ref><ref name = MS>{{cite web|title=mirtazapine (Rx) – Remeron, Remeron SolTab|work=Medscape|publisher=WebMD|accessdate=24 October 2013|url=http://reference.medscape.com/drug/remeron-soltab-mirtazapine-342966}}</ref><ref name = "AMH">{{cite web | title = Australian Medicines Handbook | url = http://www.amh.net.au | year = 2013 | publisher = Australian Medicines Handbook Pty Ltd }}</ref><ref name = "BNF">{{cite book | title = British National Formulary (BNF) | edition = 65th | publisher = Pharmaceutical Press | pages = 1120 | isbn = 978-0857110848 }}</ref><ref>{{cite web|title=Remeron (Mirtazapine) Drug Information|url=http://www.rxlist.com/remeron-drug/side-effects-interactions.htm|website=RxList|accessdate=28 March 2016}}</ref><ref>{{cite journal | vauthors = Hummel J, Westphal S, Weber-Hamann B, Gilles M, Lederbogen F, Angermeier T, Luley C, Deuschle M, Kopf D | title = Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial | journal = The Journal of Clinical Psychiatry | volume = 72 | issue = 7 | pages = 885–91 | date = July 2011 | pmid = 21294998 | doi = 10.4088/JCP.09m05853blu }}</ref><ref>{{cite journal | vauthors = McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH | title = The effect of antidepressants on lipid homeostasis: a cardiac safety concern? | journal = Expert Opinion on Drug Safety | volume = 5 | issue = 4 | pages = 523–37 | date = July 2006 | pmid = 16774491 | doi = 10.1517/14740338.5.4.523 }}</ref>

 


 
Common (1–10% incidence) adverse effects include weakness, confusion, dizziness, [[peripheral edema]], and negative lab results like [[elevated transaminases]], elevated serum [[triglyceride]]s, and elevated total [[cholesterol]].<ref name = EMC/>

 


 
Mirtazapine is not considered to have a risk of many of the side effects often associated with other antidepressants like the SSRIs, and may actually improve certain ones when taken in conjunction with them.<ref name="pmid11607047"/><ref name="pmid10333982"/> (Those adverse effects include [[anorexia (symptom)|decreased appetite]], [[weight loss]], [[insomnia]], [[nausea]] and [[vomiting]], [[diarrhoea]], [[urinary retention]], increased [[body temperature]], [[diaphoresis|excessive sweating]], [[mydriasis|pupil dilation]] and [[sexual dysfunction]].<ref name="pmid11607047"/><ref name="pmid10333982"/>)

 


 
In general, some antidepressants, especially SSRIs, can paradoxically exacerbate some peoples' depression or anxiety or cause [[suicidal ideation]].<ref name="pmid17143567">{{cite journal | vauthors = Möller HJ | title = Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review | journal = European Archives of Psychiatry and Clinical Neuroscience | volume = 256 | issue = 8 | pages = 476–96 | date = December 2006 | pmid = 17143567 | doi = 10.1007/s00406-006-0689-8 }}</ref> Despite its sedating action, mirtazapine is also believed to be capable of this, so in the United States and certain other countries, it carries a [[boxed warning|black box]] label warning of these potential effects.

 


 
A case report published in 2000 noted an instance in which mirtazapine counteracted the action of [[clonidine]], causing a dangerous rise in blood pressure.<ref>{{cite journal | vauthors = Abo-Zena RA, Bobek MB, Dweik RA | title = Hypertensive urgency induced by an interaction of mirtazapine and clonidine | journal = Pharmacotherapy | volume = 20 | issue = 4 | pages = 476–8 | date = April 2000 | pmid = 10772378 | doi = 10.1592/phco.20.5.476.35061 }}</ref>

 

